Edge Wealth Management LLC Crispr Therapeutics Ag Transaction History

Edge Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$53.19 - $79.24 $1,063 - $1,584	-20 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$70.09 - $111.29 $350 - $556	5 Added 33.33%	20 $2,000
Q4 2021 Jan 14, 2022	SELL	$70.09 - $111.29 $350 - $556	-5 Reduced 25.0%	15 $2,000
Q3 2020 Oct 21, 2020	SELL	$78.5 - $100.64 $19,625 - $25,160	-250 Reduced 92.59%	20 $2,000
Q1 2020 Apr 20, 2020	SELL	$33.68 - $62.53 $4.98 Million - $9.24 Million	-147,799 Reduced 99.82%	270 $11,000
Q4 2019 Jan 29, 2020	BUY	$36.68 - $73.13 $5.43 Million - $10.8 Million	148,049 Added 740245.0%	148,069 $2.4 Million
Q3 2019 Oct 21, 2019	BUY	$40.99 - $52.56 $819 - $1,051	20 New	20 $0

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.